AHRQ and FDA to Collaborate in Largest Study Ever of
AHRQ and FDA to Collaborate in Largest Study Ever of Possible Heart Risks With ADHD Medications
Two U.S. Department of Health and Human Services agencies will collaborate in the most comprehensive study to date of prescription medications used to treat attention deficit hyperactivity disorder (ADHD) and the potential for increased risk of heart attack, stroke or other cardiovascular problems.